Avaliação da função renal no contexto da oncologia pediátrica

Abstract

Childhood cancer accounts for 7,790 new cases per year in Brazil between 2023 and 2025, with leukemia, central nervous system tumors, and lymphomas being the most common. Treatment, especially with chemotherapy, can cause adverse effects, such as nephrotoxicity, requiring monitoring of renal function. Therefore, there is a need to organize nursing care for the pediatric oncology population, and the Pediatric Patient Classification Instrument (PPCI) can be used, which aims to measure nursing care and clinically evaluate each child or adolescent undergoing cancer treatment. Therefore, the objective of this study is to relate the measurement of renal function assessment, based on serum markers of pediatric oncology patients, with a pediatric patient classification system. This research is a quantitative, observational, analytical, cross-sectional study conducted with children and adolescents in a pediatric oncology inpatient unit, collecting sociodemographic and clinical data. The markers urea and plasma creatinine showed a positive relationship when correlated with the ICPP score, showing a higher score on the instrument, meaning that these patients require greater care from the nursing team. There was no statistical evidence between the instrument and the mean creatinine clearance. Finally, it is evident that patients who present alterations in clinical measures of renal function assessment also present a higher level of nursing care in the ICPP.